News ArticleLaurus Labs Reports ₹40,576.70 Lakh Revenue and ₹27,399.40 Lakh Net Profit After Tax in First Half of 2026
Consolidated earnings per share reach ₹3.08 for half-year ended September 30, 2026, reflecting growth over the corresponding 2025 period
Laurus Labs Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported consolidated total income from operations of ₹40,576.70 lakh and a net profit after tax of ₹27,399.40 lakh for the half-year ended September 30, 2026, compared to ₹18,326.81 lakh income and ₹12,334.67 lakh net profit for the quarter ended September 30, 2025. Earnings per share stood at ₹3.08 basic and diluted for the half-year.
Laurus Labs Limited
General / Other
Laurus Labs Limited disclosed its unaudited consolidated financial results for the quarter and half-year ended September 30, 2026, with total income from operations reaching ₹40,576.70 lakh for the half-year and net profit after tax of ₹27,399.40 lakh.
For the quarter ended September 30, 2026, the company reported a consolidated total income from operations of ₹20,295.76 lakh and a net profit after tax of ₹13,923.73 lakh.
Compared to the same quarter in 2025, the consolidated total income from operations was ₹18,326.81 lakh and net profit after tax was ₹12,334.67 lakh.
Standalone results showed a total income from operations of ₹20,679.44 lakh and net profit after tax of ₹13,283.39 lakh for the quarter ended September 30, 2026.
Earnings per share on a consolidated basis for the half-year were ₹3.08, on a Re. 1 per share basis, both basic and diluted.
The financial results have been reviewed by the Audit Committee and approved by the Board of Directors on October 29, 2026.
Highlights
- Consolidated total income from operations for half-year ended September 30, 2026 was ₹40,576.70 lakh.
- Consolidated net profit after tax for the half-year was ₹27,399.40 lakh.
- Earnings per share (basic and diluted) stood at ₹1.56 for the quarter and ₹3.08 for the half-year, based on a Re. 1 share.
- Standalone net profit after tax for the half-year ended September 30, 2026 was ₹25,952.53 lakh.
- Results were published in Business Standard (English) and Prajasakti (Telugu) newspapers on October 30, 2026.
Key Data Snapshot
What happened
- Laurus Labs released its unaudited financial results for the quarter and half-year ended September 30, 2026.
- The financial results include both Consolidated and Standalone figures.
- The results were approved by the Board of Directors on October 29, 2026, and published on October 30, 2026.
Key details
- Consolidated total income from operations for the half-year ended September 30, 2026 was ₹40,576.70 lakh.
- Consolidated net profit after tax for the same period was ₹27,399.40 lakh.
- Earnings per share for the half-year (basic and diluted) were ₹3.08 based on Re. 1 equity share.
- Standalone total income from operations for the quarter ended September 30, 2026 was ₹20,679.44 lakh.
- The company's equity share capital remains ₹8,908.95 lakh.
Regulatory and governance context
- The results are unaudited and have been reviewed by the Audit Committee.
- They were filed under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The full financial results are available on the BSE, NSE, and Laurus Labs website.
Highlights
- Consolidated total income from operations for half-year ended September 30, 2026 was ₹40,576.70 lakh.
- Consolidated net profit after tax for the half-year was ₹27,399.40 lakh.
- Earnings per share (basic and diluted) stood at ₹1.56 for the quarter and ₹3.08 for the half-year, based on a Re. 1 share.
- Standalone net profit after tax for the half-year ended September 30, 2026 was ₹25,952.53 lakh.
- Results were published in Business Standard (English) and Prajasakti (Telugu) newspapers on October 30, 2026.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30, 33 and 47
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
GAIL (India) Limited Reports ₹11,611.44 Crore Profit Before Tax for Q2 and H1 FY2026-27
GAIL (India) Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording ₹11,611.44 crore profit before tax for the half year and total income of ₹86,116.52 crore.
Read Full Story
Max Healthcare Approves Q2 2026 Financial Results and Major Expansion Projects in Noida and Vaishali
Max Healthcare Institute Limited has approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Board also approved capital expenditure plans totaling approximately ₹190 Crore to expand its hospitals in Noida and Vaishali, and revised the Gurugram hospital project cost and timeline.
Read Full Story
Max Healthcare Q2 FY27 Revenue Rises 20% to ₹3,219 Crore; PAT Increases 10% to ₹448 Crore
Max Healthcare Institute Limited reported a 20% year-on-year increase in gross revenue to ₹3,219 crore for the second quarter ended September 30, 2026, alongside a 10% rise in profit after tax to ₹448 crore. Operational bed capacity expanded by 16% year-on-year to 5,518 beds, supporting increased patient service volume.
Read Full Story
